查詢結果分析
相關文獻
- Fluoroquinolone於結核病治療的角色
- Clinical Evaluation of the Efficacy, Safety and Tolerance of Intramuscularly Administered Imipenem/cilastatin in Patients with Mild to Severe Infections
- Short-term Efficacy and Safety of Bisoprolol in Treatment of Patients with Mild-to-Moderate Essential Hypertension--A Two-center, Double-blind Study in Taiwan
- 化粧保養品的管理與檢測
- 製劑技術對藥物有效性及安全性之影響
- 化粧品添加中藥材研究
- 中草藥可添加於化妝品之品項資料研究與安全性及有效性評估
- 中草藥在皮膚保養品之應用開發
- 威爾森氏症常見藥物療法有效性及安全性之文獻回顧分析
- Efficacy and Safety of Two Different Regimens of Irinotecan for Metastatic Colorectal Cancer: Experience in a Southern Taiwan Medical Center
頁籤選單縮合
題 名 | Fluoroquinolone於結核病治療的角色=The Role of Fluoroquinolone in Tuberculosis |
---|---|
作 者 | 楊淑珍; 陳家豪; 鄭高珍; 陳麗芳; | 書刊名 | 內科學誌 |
卷 期 | 21:1 2010.02[民99.02] |
頁 次 | 頁32-41 |
分類號 | 418.2219 |
關鍵詞 | 結核菌; 有效性; 安全性; Fluoroquinolone; Tuberculosis; Efficacy; Safety; |
語 文 | 中文(Chinese) |
中文摘要 | 隨著研究的發展,fluoroquinolone 的選擇於結核治療指引有所不同。經過活性結構的修飾,新一代fluoroquinolone 展現卓越的抗結核效果;本文藉由探討fluoroquinolone 的結構相關特性與藥物動力學表現,並參照臨床使用fluoroquinolone 於結核治療的試驗結果,逐一比較不同世代的fluoroquinolone 如ofloxacin 、ciprofloxacin 、levofloxacin 、moxifloxacin 、gatifloxacin 及sparfloxacin 在長期結核病治療的有效性與安全性。最後彙整治療指引,再次檢視fluoroquinolone 於結核治療的角色、使用時機與相關應注意的事項,希望提供臨床選擇使用fluoroquinolone 之參考依據。 |
英文摘要 | Fluoroquinolones are used to treat tuberculosis based on in vitro and clinical studies. Recently, WHO recommened later-generation of fluoroquinolones, levofloxacin and moxifloxacin rather than ciprofloxacin as antituberculosis in the management of patients with ofloxacin resistance. Studies showing the different potency between older and newer-generation of fluoroquinolones in vitro and in vivo are discussed in this article. Besides, optimal policy was referred according to the pharmacodynamic properties of fluoroquinolones and the guidelines of antituberculosis. We evaluated the efficacy, susceptibility, pharmacodynamics and safety concern as clinical factors to choose the most appropriate fluoroquinolone for antituberculosis. |
本系統中英文摘要資訊取自各篇刊載內容。